Author Archives: Ilona Koebsch

The Microbial CDMO: Process Development and Manufacturing of Biologics

Wacker Biotech is “The Microbial CMO†— the partner of choice for process development and contract manufacturing of biopharmaceuticals (proteins, vaccines, and live microbial products) using microbial hosts. WACKER’s integrated service portfolio covers molecular biology, process/analytical development, and good manufacturing practice (GMP) manufacturing of biologics for clinical and commercial supply. WACKER operates three state-of-the-art GMP facilities located in Europe (Germany and The Netherlands). Manufacturing lines with two 300-L and two 1,500-L stainless steel fermentation vessels, single-use fermentation lines, matching downstream…

The Microbial CMO: Process Development and Manufacturing of Biologics

Wacker Biotech is “The Microbial CMO†— the partner of choice for contract manufacturing of therapeutic proteins using microbial hosts. Our service portfolio covers molecular biology, process and analytical development, and the GMP production of biologics for clinical trials and commercial supply. Founded in 1999 as a spin-off from the Hans-Knöll Institute in Jena, we are a 100% subsidiary of Wacker Chemie AG since 2005. The sites in Jena and Halle provide a complete range of services for the development…

The Microbial CMO: Process Development and Manufacturing of Biologics

Wacker Biotech is “The Microbial CMO†— the partner of choice for contract manufacturing of therapeutic proteins using microbial hosts. Our service portfolio covers molecular biology, process and analytical development, and the GMP production of biologics for clinical trials and commercial supply. Founded in 1999 as a spin-off from the Hans-Knöll Institute in Jena, we are a 100% subsidiary of Wacker Chemie AG since 2005. The sites in Jena and Halle provide a complete range of services for the development…

The Microbial CMO: Process Development and Manufacturing of Biologics

Wacker Biotech is “The Microbial CMO†— the partner of choice for contract manufacturing of therapeutic proteins using microbial hosts. Our service portfolio covers molecular biology, process and analytical development, and the GMP manufacturing of biologics for clinical trials and commercial supply. Founded in 1999 as a spin‑off from the Hans‑Knöll Institute in Jena, Germany, we are a 100% subsidiary of Wacker Chemie AG since 2005. Read the full text of this application note in the PDF (Login required).